3 Uses for Historical Versions of the FDA Orange Book
Listen to this article Copyright © DrugPatentWatch. Originally published at 3 Uses for Historical Versions of the FDA Orange Book Officially known as Approved Drug Products With Therapeutic Equivalence Evaluations,…
Read more
Get single drug patent reports at DrugPatentWatch
Copyright © DrugPatentWatch. Originally published at Get single drug patent reports at DrugPatentWatch Many readers have been asking for a simple way to get information on just a few drugs.…
Read more
Make Better Decisions With DrugPatentWatch
Copyright © DrugPatentWatch. Originally published at Make Better Decisions With DrugPatentWatch MAKE BETTER DECISIONS Join the 500+ leading biopharmaceutical companies we have served and make better decisions with DrugPatentWatch’s deep…
Read more
Integrate DrugPatentWatch Into Your Application or Data Store
Copyright © DrugPatentWatch. Originally published at Integrate DrugPatentWatch Into Your Application or Data Store Get Customized Access to DrugPatentWatch’s Rich Database DrugPatentWatch provides deep actionable business intelligence on small-molecule drugs…
Read more
What are the top Biopharmaceutical Business Intelligence Services?
Copyright © DrugPatentWatch. Originally published at What are the top Biopharmaceutical Business Intelligence Services? A guide for portfolio managers, business analysts, formulary directors, and more… Navigating the myriad service providers…
Read more
Ranking Biotechnology Innovation Country-by-Country
Copyright © DrugPatentWatch. Originally published at Ranking Biotechnology Innovation Country-by-Country Where does your country rank? Applications of biotechnology range from advanced medicines to and improvements in agriculture and biofuels, and…
Read more
Publish With DrugPatentWatch
Copyright © DrugPatentWatch. Originally published at Publish With DrugPatentWatch Share your expertise with our expansive network > Go to submission form < Do you want to reach a large and…
Read more

New patent for Janssen Prods drug PREZISTA

Annual Drug Patent Expirations for PREZISTA

Prezista is a drug marketed by Janssen Prods
and is included in two NDAs. It is available from six suppliers. There are four patents protecting this drug and two Paragraph IV challenges.

The generic ingredient in PREZISTA is darunavir ethanolate. Six suppliers are listed for this compound. Additional details are available on the darunavir ethanolate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com

Published in Patent Added

New patent for Janssen Prods drug PREZISTA

Share this:

Related